An Act relative to substance use prevention
The committee on Ways and Means to whom was committed the Senate Bill to improve the accessibility and affordability of naloxone and other pharmaceutical drugs of public health concern (Senate, No. 603) (the committee on Rules having recommended that the bill be amended by substituting a new draft with the same title (Senate, No. 2010)),-- reports recommending that the proposed Rules amendment be amended by substituting a new draft entitled “An Act relative to substance use prevention” (Senate, No. 2020) [Estimated cost: $1,200,000] (Senator Keenan dissenting)
The House has not filed any amendments for this bill or has yet to receive this bill from the other branch.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.